Acetylcholine receptor antibody
Acetylcholine receptor antibody
Acetylcholine receptor antibody is a protein found in the blood of most people with myasthenia gravis. The antibody affects a chemical that sends signals from nerves to muscles and between nerves in the brain.
This article discusses the blood test for acetylcholine receptor antibody.
How the test is performed
A blood sample is needed. For information on how this is done, see: Venipuncture
How to prepare for the test
No special preparation is required.
How the test will feel
There may be a slight stinging or pricking sensation when blood is drawn, but this is usually mild and brief.
Why the test is performed
This test is used to help diagnose myasthenia gravis.
Normally, there is no acetylcholine receptor antibody (or less than 0.05 nmol/L) in the bloodstream.
Note: nmol = nanomole
Note: Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.
The example above shows the common measurement for results for these tests. Some laboratories use different measurements or may test different specimens.
What abnormal results mean
An abnormal result means acetylcholine receptor antibody has been detected in your blood. It confirms the diagnosis of myasthenia gravis in people who have symptoms. Nearly half of people with myasthenia gravis limited to their eye muscles (ocular myasthenia gravis) have this antibody in their blood.
However, the lack of this antibody does not rule out myasthenia gravis. About 1 in 5 people with myasthenia gravis do not have signs of this antibody in their blood.
What the risks are
There is very little risk involved with having your blood taken. Veins and arteries vary in size from one patient to another and from one side of the body to the other. Taking blood from some people may be more difficult than from others.
Other risks associated with having blood drawn are slight but may include:
- Excessive bleeding
- Fainting or feeling light-headed
- Hematoma (blood accumulating under the skin)
- Infection (a slight risk any time the skin is broken)
Vincent A, Newson-Davis J. Disorders of neuromuscular transmission. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier. 2007: chap 448.
Sanders DB, Howard JF Jr. Disorders of neuromuscular transmission. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, eds. Bradley: Neurology in Clinical Practice. 5th ed. Philadelphia, Pa: Butterworth-Heinemann Elsevier; 2008:chap 82.
Reviewed by:Kevin Sheth, MD, Department of Neurology, University of Maryland School of Medicine, Baltimore, MD. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine;David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC'saccreditation program is an independent audit to verify that A.D.A.M. follows rigorousstandards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information andservices. Learn more about A.D.A.M.'s editorialpolicy, editorialprocess, and privacypolicy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch.)
The information provided herein should not be used during any medical emergency or for the diagnosis or treatmentof any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions.Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 2013 A.D.A.M., Inc. Any duplication ordistribution of the information contained herein is strictly prohibited.